{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:00:42Z","timestamp":1773295242252,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10620-021-06878-7","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T11:04:00Z","timestamp":1613127840000},"page":"559-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma"],"prefix":"10.1007","volume":"67","author":[{"given":"Ya-Ping","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Ning","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Qun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Yong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"6878_CR1","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1002\/cncr.25485","volume":"116","author":"XY Huang","year":"2010","unstructured":"Huang XY, Ke AW, Shi GM, Ding ZB, Devbhandari RP, Gu FM, Li QL, Dai Z, Zhou J, Fan J. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer 2010;116:5440\u20135451.","journal-title":"Cancer"},{"key":"6878_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12957-018-1540-1","volume":"17","author":"C Wang","year":"2019","unstructured":"Wang C, Pang S, Si-Ma H, Yang N, Zhang H, Fu Y, Yang G. Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection. World J Surg Oncol 2019;17:2.","journal-title":"World J Surg Oncol"},{"key":"6878_CR3","doi-asserted-by":"publisher","first-page":"37520","DOI":"10.18632\/oncotarget.26494","volume":"9","author":"T Shintani","year":"2018","unstructured":"Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, Kashiwagi Y, Sato A, Obana M, Yamamoto A, Kawasaki K, Lin Y, Kijima T, Kinehara Y, Miwa Y, Maeda S, Morii E, Kumanogoh A, Tsutsumi Y, Nagatomo I, Fujio Y. Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer. Oncotarget 2018;9:37520\u201337533.","journal-title":"Oncotarget"},{"key":"6878_CR4","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, Cheng C, Li L, Pi J, Si Y, Xiao H, Li L, Rao S, Wang F, Yu J, Yu J, Zou D, Yi P. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucl Acids Res 2020;48:3816\u20133831.","journal-title":"Nucl Acids Res"},{"key":"6878_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2013.04.026","volume":"336","author":"R Emmanuel","year":"2013","unstructured":"Emmanuel R, Weinstein S, Landesman-Milo D, Peer D. eIF3c: a potential therapeutic target for cancer. Cancer Lett 2013;336:158\u2013166.","journal-title":"Cancer Lett"},{"key":"6878_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd4505","volume":"14","author":"M Bhat","year":"2015","unstructured":"Bhat M, Robichaud N, Hulea L, Sonenberg N, Pelletier J, Topisirovic I. Targeting the translation machinery in cancer. Nat Rev Drug Discov 2015;14:261\u2013278.","journal-title":"Nat Rev Drug Discov"},{"key":"6878_CR7","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.2147\/OTT.S149361","volume":"10","author":"R Peng","year":"2017","unstructured":"Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D. Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance. Onco Targets Ther 2017;10:5863\u20135872.","journal-title":"Onco Targets Ther"},{"key":"6878_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/cam4.1313","volume":"7","author":"R Peng","year":"2018","unstructured":"Peng R, Zhang PF, Zhang C, Huang XY, Ding YB, Deng B, Bai DS, Xu YP. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling. Cancer Med 2018;7:796\u2013808.","journal-title":"Cancer Med"},{"key":"6878_CR9","doi-asserted-by":"publisher","first-page":"BSR20191124","DOI":"10.1042\/BSR20191124","volume":"39","author":"F Wen","year":"2019","unstructured":"Wen F, Wu ZY, Nie L, Zhang QZ, Qin YK, Zhou ZL, Wu JJ, Zhao X, Tan J, Sawmiller D, Zi D. Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells. Biosci Rep 2019;39:BSR20191124.","journal-title":"Biosci Rep"},{"key":"6878_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","volume":"379","author":"H Zhang","year":"2016","unstructured":"Zhang H, Yang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett 2016;379:198\u2013205.","journal-title":"Cancer Lett"},{"key":"6878_CR11","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1038\/s41419-017-0015-6","volume":"8","author":"N Xie","year":"2017","unstructured":"Xie N, Cai JB, Zhang L, Zhang PF, Shen YH, Yang X, Lu JC, Gao DM, Kang Q, Liu LX, Zhang C, Huang XY, Zou H, Zhang XY, Song ZJ, Sun HX, Fu BM, Ke AW, Shi GM. Upregulation of B7\u2013H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Cell Death Dis 2017;8:3205.","journal-title":"Cell Death Dis"},{"key":"6878_CR12","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729241","volume":"24","author":"YS Chun","year":"2017","unstructured":"Chun YS, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma. Cancer Control 2017;24:1073274817729241.","journal-title":"Cancer Control"},{"key":"6878_CR13","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/nar\/gkr1083","volume":"40","author":"T Kouba","year":"2012","unstructured":"Kouba T, Rutkai E, Karaskova M, Valasek L. The eIF3c\/NIP1 PCI domain interacts with RNA and RACK1\/ASC1 and promotes assembly of translation preinitiation complexes. Nucl Acids Res 2012;40:2683\u20132699.","journal-title":"Nucl Acids Res"},{"key":"6878_CR14","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.18632\/oncotarget.24149","volume":"9","author":"HY Lee","year":"2018","unstructured":"Lee HY, Chen CK, Ho CM, Lee SS, Chang CY, Chen KJ, Jou YS. EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma. Oncotarget 2018;9:13193\u201313205.","journal-title":"Oncotarget"},{"key":"6878_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-cellbio-111315-125249","volume":"33","author":"CAP Joazeiro","year":"2017","unstructured":"Joazeiro CAP. Ribosomal stalling during translation: providing substrates for ribosome-associated protein quality control. Annu Rev Cell Dev Biol 2017;33:343\u2013368.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"6878_CR16","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.celrep.2017.02.052","volume":"18","author":"E Obayashi","year":"2017","unstructured":"Obayashi E, Luna RE, Nagata T, Martin-Marcos P, Hiraishi H, Singh CR, Erzberger JP, Zhang F, Arthanari H, Morris J, Pellarin R, Moore C, Harmon I, Papadopoulos E, Yoshida H, Nasr ML, Unzai S, Thompson B, Aube E, Hustak S, Stengel F, Dagraca E, Ananbandam A, Gao P, Urano T, Hinnebusch AG, Wagner G, Asano K. Molecular landscape of the ribosome pre-initiation complex during mRNA scanning: structural role for eIF3c and its control by eIF5. Cell Rep 2017;18:2651\u20132663.","journal-title":"Cell Rep"},{"key":"6878_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","volume":"136","author":"N Sonenberg","year":"2009","unstructured":"Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009;136:731\u2013745.","journal-title":"Cell"},{"key":"6878_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1631\/jzus.B1200230","volume":"14","author":"N Song","year":"2013","unstructured":"Song N, Wang Y, Gu XD, Chen ZY, Shi LB. Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells. J Zhejiang Univ Sci B. 2013;14:451\u2013459.","journal-title":"J Zhejiang Univ Sci B."},{"key":"6878_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/OTT.S187209","volume":"12","author":"W Gao","year":"2019","unstructured":"Gao W, Hu Y, Zhang Z, Du G, Yin L, Yin Z. Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3\/7 and Chk1\/2 by upregulating SAPK\/JNK. Onco Targets Ther 2019;12:1225\u20131235.","journal-title":"Onco Targets Ther"},{"key":"6878_CR20","first-page":"1385","volume":"55","author":"M Fan","year":"2019","unstructured":"Fan M, Wang K, Wei X, Yao H, Chen Z, He X. Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma. Int J Oncol 2019;55:1385\u20131395.","journal-title":"Int J Oncol"},{"key":"6878_CR21","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.3390\/ijms20246169","volume":"20","author":"MA Smolle","year":"2019","unstructured":"Smolle MA, Czapiewski P, Lapinska-Szumczyk S, Majewska H, Supernat A, Zaczek A, Biernat W, Golob-Schwarzl N, Haybaeck J. The prognostic significance of eukaryotic translation initiation factors (eIFs) in endometrial cancer. Int J Mol Sci 2019;20:6169.","journal-title":"Int J Mol Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06878-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T15:33:53Z","timestamp":1646062433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06878-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6878"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06878-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"We confirm that there is no potential conflict of interest or financial dependence regarding this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}